Report for Ramos E

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer's disease therapy - Romero_2020_Neural.Regen.Res_15_30
Author(s) : Romero A , Marco-Contelles J , Ramos E
Ref : Neural Regen Res , 15 :30 , 2020
Abstract : Romero_2020_Neural.Regen.Res_15_30
ESTHER : Romero_2020_Neural.Regen.Res_15_30
PubMedSearch : Romero_2020_Neural.Regen.Res_15_30
PubMedID: 31535639

Title : New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer s disease endowed with neurogenic properties - Estrada-Valencia_2019_J.Enzyme.Inhib.Med.Chem_34_712
Author(s) : Estrada-Valencia M , Herrera-Arozamena C , Perez C , Vina D , Morales-Garcia JA , Perez-Castillo A , Ramos E , Romero A , Laurini E , Pricl S , Rodriguez-Franco MI
Ref : J Enzyme Inhib Med Chem , 34 :712 , 2019
Abstract : Estrada-Valencia_2019_J.Enzyme.Inhib.Med.Chem_34_712
ESTHER : Estrada-Valencia_2019_J.Enzyme.Inhib.Med.Chem_34_712
PubMedSearch : Estrada-Valencia_2019_J.Enzyme.Inhib.Med.Chem_34_712
PubMedID: 31852270

Title : QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy - Ramos_2019_Molecules_24_
Author(s) : Ramos E , Palomino-Antolin A , Bartolini M , Iriepa I , Moraleda I , Diez-Iriepa D , Samadi A , Cortina CV , Chioua M , Egea J , Romero A , Marco-Contelles J
Ref : Molecules , 24 : , 2019
Abstract : Ramos_2019_Molecules_24_
ESTHER : Ramos_2019_Molecules_24_
PubMedSearch : Ramos_2019_Molecules_24_
PubMedID: 30999586

Title : Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease - Estrada_2018_Eur.J.Med.Chem_156_534
Author(s) : Estrada Valencia M , Herrera-Arozamena C , de Andres L , Perez C , Morales-Garcia JA , Perez-Castillo A , Ramos E , Romero A , Vina D , Yanez M , Laurini E , Pricl S , Rodriguez-Franco MI
Ref : Eur Journal of Medicinal Chemistry , 156 :534 , 2018
Abstract : Estrada_2018_Eur.J.Med.Chem_156_534
ESTHER : Estrada_2018_Eur.J.Med.Chem_156_534
PubMedSearch : Estrada_2018_Eur.J.Med.Chem_156_534
PubMedID: 30025348

Title : Upregulation of Antioxidant Enzymes by ASS234, a Multitarget Directed Propargylamine for Alzheimer's Disease Therapy -
Author(s) : Ramos E , Romero A , Marco-Contelles J , Del Pino J
Ref : CNS Neurosci Ther , 22 :799 , 2016
PubMedID: 27380946

Title : Wnt signaling pathway, a potential target for Alzheimer's disease treatment, is activated by a novel multitarget compound ASS234 -
Author(s) : Del Pino J , Ramos E , Aguilera OM , Marco-Contelles J , Romero A
Ref : CNS Neurosci Ther , 20 :568 , 2014
PubMedID: 24712554